Neuromed Pharmaceuticals Ltd.

Canada

Create a watch for Neuromed Pharmaceuticals Ltd.
Total IP 10
Total IP Rank # 157,514
IP Activity Score 0/5.0    0
IP Activity Rank # 1,709,712

Patents

Trademarks

0 0
0 0
10 0
0
 
Last Patent 2013 - Substituted aryl sulfone derivat...
First Patent 1999 - Methods to inactivate n-type cal...

Latest Inventions, Goods, Services

2012 Invention Substituted aryl sulfone derivatives as calcium channel blockers. A series of substituted aryl s...
2008 Invention Substituted aryl sulfone derivatives as calcium channel blockers. A series of substituted aryl su...
Invention Substituted aryl sulfone derivatives as calcium channel blockers.
A series of substitu...
Invention Amino acid derivatives as calcium channel blockers. Methods and compounds effective in ameliorati...
Invention Bicyclic pyrimidine derivatives as calcium channel blockers. Methods and compounds effective in a...
Invention Amide derivatives as calcium channel blockers. Methods and compounds effective in ameliorating co...
2007 Invention Cyclopropyl-piperazine compounds as calcium channel blockers. Methods and compounds effective in ...
Invention Diaryl piperidine compounds as calcium channel blockers. Methods and compounds effective in ameli...
Invention Heterocyclic compounds as calcium channel blockers. Methods and compounds effective in ameliorati...
Invention Method for increasing the bioavailability of benzhydryl piperazine containing compounds. A method...
Invention Isoxazole derivatives as calcium channel blockers. Methods and compounds effective in amelioratin...
2006 Invention Heterocyclic amide derivatives as calcium channel blockers. Methods and compounds effective in am...
Invention Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain. The...
Invention Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain.
Invention Diamine calcium channel blockers. Aromatic derivatives of aliphatic diamines are effective in ame...
Invention Diamine calcium channel blockers.
Aromatic derivatives of aliphatic diamines are effec...
2005 Invention Urea derivatives as calcium channel blockers. Urea derivatives of formula (1) which comprise pipe...
Invention Urea derivatives as calcium channel blockers.
Urea derivatives of formula (1) which co...
Invention T-type calcium channel splice variant compositions and methods. Cell proliferative conditions are...
Invention T-type calcium channel splice variant compositions and methods.
Cell proliferative con...
Invention Diarylamine derivatives as calcium channel blockers. N-diarylaminoalkyl-substituted piperazine/4-...
Invention Diarylamine derivatives as calcium channel blockers.
N-diarylaminoalkyl-substituted pi...
Invention N-type calcium channel blockers. The present invention relates to 3-amino pyrrolidine derivatives...
2004 Invention 3-aminomethyl-pyrrolidines as n-type calcium channel blockers.
The invention relates t...
Invention Calcium channel blockers comprising two benzhydril moieties.
Certain piperazine substi...
Invention Calcium channel inhibitors comprising benzhydril spaced from piperazine.
Certain piper...
Invention Fluorescence based t-type channel assay.
A fluorescence based assay for compounds that...
2000 Invention 5,10-dihydroacridines as calcium channel blockers.
Compounds of formula (1a) or (1b) o...
1999 Invention Methods to inactivate n-type calcium channels.
Compounds comprising an unbranched back...